Hiroaki Kanki

1.1k citations
15 papers · 890 indexed · h-index 13

Hiroaki Kanki

15 papers receiving 880 citations

Peers

Hiroaki Kanki
Comparison fields: 5 of 85
  • Developmental Neuroscience 112
  • Cellular and Molecular Neuroscience 231
  • Physiology 43
  • Molecular Biology 592
  • Cancer Research 103
Replace Magdalena Dziembowska with:
Magdalena Dziembowska Poland
Peter S. Walmod Denmark
F. Besnard France
Raul Krauss United States
Derek Solum United States
Guido Hermey Germany
Aleksandra Janusz Poland
Jelena Mojsilovic‐Petrovic United States
Guillermo López‐Doménech United Kingdom
Marjelo A. Mines United States
Hiroaki Kanki relative to Magdalena Dziembowska Poland Magdalena Dziembowska's profile →
Citations per field
00.5×1.5×1.9×
Magdalena Dziembowska · 1×
Citations per year

Countries citing papers authored by Hiroaki Kanki

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Kanki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kanki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kanki more than expected).

Fields of papers citing papers by Hiroaki Kanki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kanki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kanki. The network helps show where Hiroaki Kanki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hiroaki Kanki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroaki Kanki Line = papers co-authored together Hiroaki Kanki links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 20197
2 201452
3 201260
4 2011156
5 201012
6 200919
7 200863
8 200739
9 2006122
10 200118
11 200044
12 19987
13 199864
14 1997117
15 1995110

About Hiroaki Kanki

Hiroaki Kanki is a scholar working on Developmental Neuroscience, Neurology and Physiology, having authored 15 papers that have together received 890 indexed citations. Recurring topics across this work include Neurogenesis and neuroplasticity mechanisms (6 papers), Cell death mechanisms and regulation (3 papers), Ubiquitin and proteasome pathways (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Genetics and Neurodevelopmental Disorders (2 papers), MicroRNA in disease regulation (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Developmental Neuroscience (112 citations), Cellular and Molecular Neuroscience (231 citations) and Physiology (43 citations). Hiroaki Kanki has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Shigeyoshi Itohara, Hitomi Suzuki, Hideyuki Okano, Takaaki Sato, MM Poo, Flavia Valtorta, Paul Greengard, Janet Alder, Kazunobu Sawamoto and Eiichi Kobayashi. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026